SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-21-034702
Filing Date
2021-03-11
Accepted
2021-03-11 06:08:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D tm219419-1_sc13d.htm SC 13D 71696
2 EXHIBIT 1 tm219419d1_ex1.htm EX-99.1 74161
  Complete submission text file 0001104659-21-034702.txt   147456
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Subject) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89598 | Film No.: 21731759
SIC: 2834 Pharmaceutical Preparations

Mailing Address 64, CHEONHO-DAERO DONGDAEMUN-GU SEOUL M5 02587
Business Address 64, CHEONHO-DAERO DONGDAEMUN-GU SEOUL M5 02587 82-2-920-8184
DONG-A ST CO., LTD (Filed by) CIK: 0001799260 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M5 | Fiscal Year End: 1231
Type: SC 13D